Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Derby

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Scientific Reports|August 21, 2019
A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV InfectionInes Frank, Arpan Acharya, Nanda K Routhu, et al.
AIDS Research and Human Retroviruses|October 15, 2013
A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallengeMayla Hsu, Meropi Aravantinou, Radhika Menon, et al.
Frontiers in Microbiology|December 21, 2017
Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus MacaquesMeropi Aravantinou, Olga Mizenina, Giulia Calenda, et al.
AIDS Research and Human Retroviruses|February 24, 2023
Herpes Simplex Virus Type 2 Prevalence and Association with Inflammatory Cytokines Among Sexual and Gender Minorities Living With and Without HIV-1 from Lagos, NigeriaMeropi Aravantinou, Marlena Plagianos, Afoke Kokogho, et al.
AIDS Research and Human Retroviruses|June 29, 2012
A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel useJessica Kenney, Rachel Singer, Nina Derby, et al.
Science Translational Medicine|September 8, 2012
An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaquesRachel Singer, Paul Mawson, Nina Derby, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivoJessica Kenney, Aixa Rodríguez, Larisa Kizima, et al.
Plos Pathogens|September 26, 2025
Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsetsNina Derby, Brooke I Johnson, Sreya Biswas, et al.
AIDS Research and Human Retroviruses|July 24, 2012
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT InfectionMeropi Aravantinou, Rachel Singer, Nina Derby, et al.
Viruses|February 24, 2024
SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In VivoNina Derby, Sreya Biswas, Sofiya Yusova, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Scientific Reports|August 21, 2019
A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV InfectionInes Frank, Arpan Acharya, Nanda K Routhu, et al.
AIDS Research and Human Retroviruses|October 15, 2013
A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallengeMayla Hsu, Meropi Aravantinou, Radhika Menon, et al.
Frontiers in Microbiology|December 21, 2017
Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus MacaquesMeropi Aravantinou, Olga Mizenina, Giulia Calenda, et al.
AIDS Research and Human Retroviruses|February 24, 2023
Herpes Simplex Virus Type 2 Prevalence and Association with Inflammatory Cytokines Among Sexual and Gender Minorities Living With and Without HIV-1 from Lagos, NigeriaMeropi Aravantinou, Marlena Plagianos, Afoke Kokogho, et al.
AIDS Research and Human Retroviruses|June 29, 2012
A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel useJessica Kenney, Rachel Singer, Nina Derby, et al.
Science Translational Medicine|September 8, 2012
An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaquesRachel Singer, Paul Mawson, Nina Derby, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2013
A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivoJessica Kenney, Aixa Rodríguez, Larisa Kizima, et al.
Plos Pathogens|September 26, 2025
Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsetsNina Derby, Brooke I Johnson, Sreya Biswas, et al.
AIDS Research and Human Retroviruses|July 24, 2012
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT InfectionMeropi Aravantinou, Rachel Singer, Nina Derby, et al.
Viruses|February 24, 2024
SIV Infection Is Associated with Transient Acute-Phase Steatosis in Hepatocytes In VivoNina Derby, Sreya Biswas, Sofiya Yusova, et al.
Pageof 3